Once valued at $6 billion, executives have yet to find a bidder for the $50 million gene testing company that has never turned a profit.

The genetic testing company has filed for bankruptcy protection and it's unclear what will happen to its massive collection of customer data.

The genetic testing company 23andMe is filing for bankruptcy and looking for a new buyer. The company announced the move after losing millions of dollars over the last several quarters.

Genetics company 23andMe has filed for bankruptcy and its CEO is stepping down, leaving many users concerned about the future of their data.

Gene testing firm 23andMe said on Sunday it had filed for Chapter 11 bankruptcy protection in order to facilitate its sale, after years of struggling to find a sustainable business model.

The company said it will look to sell “substantially all of its assets” through a court-approved reorganization plan.

The bankruptcy filing, and advice from state regulators that customers should withdraw their data from 23andMe, is almost certain to reduce that willingness. The company’s bankruptcy underscores ...

Genetic testing company 23andMe filed for Chapter 11 bankruptcy protection to help the $50 million company sell itself, the company announced Sunday. 23andMe's saliva-based kits have been helping ...

With Sunday’s announcement by genetic testing firm 23andMe that it has filed for bankruptcy, customers of the site may be wondering what will happen to their data and what, if anything, they can or ...

In the wake of this breach, 23andMe faced a costly lawsuit, which was settled in September. Shortly thereafter, the company announced layoffs affecting 40% of its workforce, a move that underscored ...

NEW YORK (AP) — 23andMe has filed for Chapter 11 bankruptcy protection and its co-founder and CEO has resigned as the struggling genetic testing company continues its push to cut costs.